ZA95834B - 3-(2-aminoethyl)-4-[3-(trifluoromethyl)benzoyl]-3, 4-dihydro-2H-1, 4-benzoxazine derivatives process for their preparation and their therapeutic application: - Google Patents
3-(2-aminoethyl)-4-[3-(trifluoromethyl)benzoyl]-3, 4-dihydro-2H-1, 4-benzoxazine derivatives process for their preparation and their therapeutic application:Info
- Publication number
- ZA95834B ZA95834B ZA95834A ZA95834A ZA95834B ZA 95834 B ZA95834 B ZA 95834B ZA 95834 A ZA95834 A ZA 95834A ZA 95834 A ZA95834 A ZA 95834A ZA 95834 B ZA95834 B ZA 95834B
- Authority
- ZA
- South Africa
- Prior art keywords
- dihydro
- aminoethyl
- benzoyl
- trifluoromethyl
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9401197A FR2715655B1 (fr) | 1994-02-03 | 1994-02-03 | Dérivés de 3-(2-aminoéthyl)-4-benzoyl-3,4-dihydro-2H-1,4-benzoxazine, leur préparation et leur application en thérapeutique. |
| FR9401196A FR2715659B1 (fr) | 1994-02-03 | 1994-02-03 | Dérivés de 3-(2-aminoéthyl)-4-[3-(trifluorométhyl)benzoyl]-3,4-dihydro-2H-1,4-benzoxazine, leur préparation et leur application en thérapeutique. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA95834B true ZA95834B (en) | 1996-02-12 |
Family
ID=26230930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA95834A ZA95834B (en) | 1994-02-03 | 1995-02-02 | 3-(2-aminoethyl)-4-[3-(trifluoromethyl)benzoyl]-3, 4-dihydro-2H-1, 4-benzoxazine derivatives process for their preparation and their therapeutic application: |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5550125A (xx) |
| EP (1) | EP0666260B1 (xx) |
| JP (1) | JPH07278123A (xx) |
| KR (1) | KR950032184A (xx) |
| CN (1) | CN1109880A (xx) |
| AT (1) | ATE182887T1 (xx) |
| AU (1) | AU687134B2 (xx) |
| CA (1) | CA2141728A1 (xx) |
| CZ (1) | CZ27095A3 (xx) |
| DE (1) | DE69511127D1 (xx) |
| FI (1) | FI950457A (xx) |
| HU (1) | HUT71238A (xx) |
| IL (1) | IL112528A (xx) |
| NO (1) | NO304229B1 (xx) |
| NZ (1) | NZ270444A (xx) |
| PL (1) | PL307040A1 (xx) |
| RU (1) | RU2136670C1 (xx) |
| SK (1) | SK12895A3 (xx) |
| ZA (1) | ZA95834B (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69828197T2 (de) | 1997-10-27 | 2005-12-08 | Sumitomo Pharmaceuticals Co., Ltd. | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut |
| JP3201998B2 (ja) * | 1998-12-16 | 2001-08-27 | サムソン ジェネラル ケミカルズ カンパニー リミテッド | （ｓ）−ベンゾオキサジン誘導体の製造方法及び（ｒ）−ベンゾオキサジン誘導体のラセミ化方法 |
| KR100397491B1 (ko) * | 2000-12-05 | 2003-09-13 | 이수화학 주식회사 | 광학활성 (ｓ)-벤즈옥사진 유도체 및 그의 제조방법 |
| CA2597616A1 (en) * | 2005-02-17 | 2006-08-24 | Wyeth | Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| BRPI0614485A2 (pt) * | 2005-07-28 | 2011-03-29 | Bristol-Myers Squibb Company | tetrahidro-1h-pirido [4, 3, b] indóis substituìdos como agonistas e antagonistas receptores de serotonina |
| JP6033835B2 (ja) | 2011-03-18 | 2016-11-30 | ルピン アトランティス ホールディングス エスエー | カルシウム感知受容体モジュレーターとしてのベンゾ［ｂ］［１，４］オキサジン誘導体 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1287584B (de) * | 1962-07-04 | 1969-01-23 | Thomae Gmbh Dr K | Verfahren zur Herstellung von 2, 3-Dihydro-1, 4-benzoxazinderivaten |
| US4636563A (en) * | 1985-09-16 | 1987-01-13 | American Home Products Corporation | Antipsychotic γ-carbolines |
| FR2619111B1 (fr) * | 1987-08-07 | 1991-01-11 | Synthelabo | Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique |
| FR2702477B1 (fr) * | 1993-03-08 | 1995-04-28 | Synthelabo | Dérivés de benzoxazine, leur préparation et leur application en thérapeutique. |
-
1995
- 1995-01-30 CN CN95101657A patent/CN1109880A/zh active Pending
- 1995-02-02 JP JP7015892A patent/JPH07278123A/ja active Pending
- 1995-02-02 NZ NZ270444A patent/NZ270444A/en unknown
- 1995-02-02 DE DE69511127T patent/DE69511127D1/de not_active Expired - Lifetime
- 1995-02-02 PL PL95307040A patent/PL307040A1/xx unknown
- 1995-02-02 NO NO950378A patent/NO304229B1/no unknown
- 1995-02-02 RU RU95101386A patent/RU2136670C1/ru active
- 1995-02-02 FI FI950457A patent/FI950457A/fi unknown
- 1995-02-02 CA CA002141728A patent/CA2141728A1/en not_active Abandoned
- 1995-02-02 SK SK128-95A patent/SK12895A3/sk unknown
- 1995-02-02 AU AU11545/95A patent/AU687134B2/en not_active Ceased
- 1995-02-02 AT AT95400215T patent/ATE182887T1/de not_active IP Right Cessation
- 1995-02-02 EP EP95400215A patent/EP0666260B1/fr not_active Expired - Lifetime
- 1995-02-02 CZ CZ95270A patent/CZ27095A3/cs unknown
- 1995-02-02 IL IL11252895A patent/IL112528A/xx not_active IP Right Cessation
- 1995-02-02 HU HU9500310A patent/HUT71238A/hu unknown
- 1995-02-02 ZA ZA95834A patent/ZA95834B/xx unknown
- 1995-02-02 US US08/382,589 patent/US5550125A/en not_active Expired - Fee Related
- 1995-02-02 KR KR1019950001835A patent/KR950032184A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ270444A (en) | 1996-02-27 |
| ATE182887T1 (de) | 1999-08-15 |
| IL112528A (en) | 1999-04-11 |
| FI950457A (fi) | 1995-08-04 |
| CA2141728A1 (en) | 1995-08-04 |
| RU95101386A (ru) | 1996-11-20 |
| AU1154595A (en) | 1995-08-10 |
| CN1109880A (zh) | 1995-10-11 |
| CZ27095A3 (en) | 1995-09-13 |
| NO304229B1 (no) | 1998-11-16 |
| SK12895A3 (en) | 1995-08-09 |
| NO950378D0 (no) | 1995-02-02 |
| AU687134B2 (en) | 1998-02-19 |
| FI950457A0 (fi) | 1995-02-02 |
| EP0666260A1 (fr) | 1995-08-09 |
| HUT71238A (en) | 1995-11-28 |
| KR950032184A (ko) | 1995-12-20 |
| US5550125A (en) | 1996-08-27 |
| PL307040A1 (en) | 1995-08-07 |
| DE69511127D1 (de) | 1999-09-09 |
| JPH07278123A (ja) | 1995-10-24 |
| HU9500310D0 (en) | 1995-03-28 |
| NO950378L (no) | 1995-08-04 |
| IL112528A0 (en) | 1995-05-26 |
| EP0666260B1 (fr) | 1999-08-04 |
| RU2136670C1 (ru) | 1999-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO950379L (no) | Karboksamidderivater, deres fremstilling og anvendelse som terapeutika | |
| PH23293A (en) | Hypotensive quinolone derivatives | |
| ZA95834B (en) | 3-(2-aminoethyl)-4-[3-(trifluoromethyl)benzoyl]-3, 4-dihydro-2H-1, 4-benzoxazine derivatives process for their preparation and their therapeutic application: | |
| NZ286756A (en) | Indole, indazole, and benzisoxazole derivatives substituted in position 3' by 4-benzoylperhydroazepin-1-ylalkyl or 3-substituted pyrrolidin-1-ylalkyl |